PET-CT could play a role in the diagnosis and treatment of pituitary adenoma/PitNET, and GH-secreting specifically ones, for detecting persistent or refractory disease and for selecting patients who are suitable for third-line therapies such as PRRT. The gene discussed is GH1; the disease is pituitary gland adenoma.